Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this clinical study is to confirm the utility of chemosensitivity tumor
testing on cancer stem cells (ChemoID) as a predictor of clinical response in poor prognosis
malignant brain tumors such as recurrent glioblastoma (GBM).